Biochemistry, Genetics and Molecular Biology
Agonist
33%
Amino Acid Substitution
24%
Androgen Receptor
99%
B Cell
15%
Bimolecular Fluorescence Complementation
14%
Binding Domain
24%
Cancer Cell
31%
Caspase
18%
CDKN1B
9%
Cell Death
24%
Corepressor
40%
Dimerization
14%
DNA Binding
24%
Downregulation
13%
Doxorubicin
24%
Epidermal Growth Factor Receptor
24%
ErbB
14%
Fas Ligand
24%
Fas Receptor
20%
Flow Cytometry
12%
GLI1
9%
Hepatocyte
10%
Histone
14%
Histone Deacetylase 2
24%
Histone Methylation
24%
Human Herpesvirus 8
24%
Hydrodynamics Based Transfection
8%
Immunoglobulin Domain
24%
Ligand Binding
34%
Messenger RNA
24%
Methylation
12%
Mouse Model
24%
N-Terminus
8%
Nuclear Matrix
24%
Nucleolin
24%
Polymorphonuclear Cell
24%
Programmed Cell Death
100%
Promyelocytic Leukemia Protein
19%
Protein L
19%
R-Factor
8%
RE1-silencing Transcription Factor
49%
Retinoic Acid Receptor
24%
Ribonucleoprotein
16%
RNA Translation
8%
Sonic Hedgehog
17%
Transactivation
39%
Transcriptional Repressor
24%
Translational Regulation
8%
Untranslated Region
16%
Wild Type
12%
Keyphrases
Akt Activation
24%
Androgen Receptor
74%
Apoptosis
27%
Brain Sparing
8%
Chromatin Compaction
24%
Coactivator
10%
Corepressor
34%
Current Treatment
16%
Doxorubicin
24%
Endocrine Sequelae
8%
Fas Expression
24%
Fluorine-19 MRI
49%
Focus Formation
24%
Gli1
9%
Hepatocellular Carcinoma
8%
Hepatocellular Carcinoma Cells
11%
High-dose Chemotherapy
8%
Hippo-YAP
24%
Histone Deacetylase 2 (HDAC2)
24%
Human Antigen R
24%
Individualized Treatment
8%
Induced Damage
24%
Intranuclear
26%
Liver Cancer
24%
Medulloblastoma
63%
Milatuzumab
24%
Mouse Model
24%
Natural Killer Cells
24%
Neurological Sequelae
8%
New Drug Targets
8%
Opposite Effects
24%
Patient Outcomes
24%
Pediatric Brain Tumor
8%
PTCH1
24%
Radiation Dose
8%
RE1-silencing Transcription Factor
24%
Resistance to Cell Death
8%
Sonic Hedgehog
12%
Splice Variant
24%
TIF2
24%
Transactivation
29%
Transcriptional Activity
8%
Transcriptional Repressor
27%
Treatment Decisions
24%
Treatment Modalities
8%
Tumor
11%
Tumor Biology
24%
Tumor-specific
8%
USP37
24%
Zinc Finger Protein
74%
Medicine and Dentistry
Acute Promyelocytic Leukemia
13%
Antigen
24%
Carcinoma Cell
8%
Cell Surface
5%
Death Receptor
5%
Doxorubicin
24%
Fas Antibody
5%
Fas Ligand
24%
Fluorine
24%
Granulocyte
24%
Hepatocellular Carcinoma
22%
Hepatocyte
5%
High Dose Chemotherapy
8%
Leukemia Cell
5%
Ligand Binding
24%
Liver Cancer
24%
Medulloblastoma
24%
Messenger RNA
8%
Nucleolin
24%
Pediatric Brain Tumor
8%
Programmed Cell Death
80%
Promyelocytic Leukemia Protein
19%
Recurrent Disease
8%
Retinoic Acid Receptor
24%
Ribonucleoprotein
5%
Sequela
8%
Specific Tumor
8%
Tumor Biology
24%
Tumor Necrosis Factor Receptor Superfamily Member 6
8%
Untranslated Region
5%